文献
J-GLOBAL ID:202002213536030335
整理番号:20A2558573
選択的神経活性ステロイドGABA_A受容体陽性アロステリックモジュレーター,ズラノロン(SAGE-217)の前臨床特性化【JST・京大機械翻訳】
Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator
著者 (16件):
Althaus Alison L.
(Research and Nonclinical Development, Sage Therapeutics, Inc., Cambridge, MA, USA)
,
Ackley Michael A.
(Research and Nonclinical Development, Sage Therapeutics, Inc., Cambridge, MA, USA)
,
Belfort Gabriel M.
(Research and Nonclinical Development, Sage Therapeutics, Inc., Cambridge, MA, USA)
,
Gee Steven M.
(Research and Nonclinical Development, Sage Therapeutics, Inc., Cambridge, MA, USA)
,
Dai Jing
(Research and Nonclinical Development, Sage Therapeutics, Inc., Cambridge, MA, USA)
,
Nguyen David P.
(Research and Nonclinical Development, Sage Therapeutics, Inc., Cambridge, MA, USA)
,
Kazdoba Tatiana M.
(Research and Nonclinical Development, Sage Therapeutics, Inc., Cambridge, MA, USA)
,
Modgil Amit
(Department of Neuroscience, Tufts University, Boston, MA, USA)
,
Davies Paul A.
(Department of Neuroscience, Tufts University, Boston, MA, USA)
,
Moss Stephen J.
(Department of Neuroscience, Tufts University, Boston, MA, USA)
,
Salituro Francesco G.
(Research and Nonclinical Development, Sage Therapeutics, Inc., Cambridge, MA, USA)
,
Hoffmann Ethan
(Research and Nonclinical Development, Sage Therapeutics, Inc., Cambridge, MA, USA)
,
Hammond Rebecca S.
(Research and Nonclinical Development, Sage Therapeutics, Inc., Cambridge, MA, USA)
,
Robichaud Albert J.
(Research and Nonclinical Development, Sage Therapeutics, Inc., Cambridge, MA, USA)
,
Quirk Michael C.
(Research and Nonclinical Development, Sage Therapeutics, Inc., Cambridge, MA, USA)
,
Doherty James J.
(Research and Nonclinical Development, Sage Therapeutics, Inc., Cambridge, MA, USA)
資料名:
Neuropharmacology
(Neuropharmacology)
巻:
181
ページ:
Null
発行年:
2020年
JST資料番号:
H0537A
ISSN:
0028-3908
CODEN:
NEPHBW
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)